Orbit Discovery Announces $7.6 Million Funding To Accelerate Growth In Peptide Discovery Business

Orbit Discovery Ltd., (“Orbit”), a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, today announced that it has raised $7.6 million (USD) in funding.